Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Eck, Michael J

Class:IdPerson:2408401
_displayNameEck, Michael J
_timestamp2012-07-17 05:52:38
created[InstanceEdit:2408398] Shamovsky, V, 2012-07-17
firstnameMichael J
initialMJ
surnameEck
(author)[LiteratureReference:2408399] Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING
[LiteratureReference:3965303] Mechanism and function of formins in the control of actin assembly
[LiteratureReference:5229002] Crystal structure of a coiled-coil domain from human ROCK I
[LiteratureReference:5362611] Structure and ubiquitination-dependent activation of TANK-binding kinase 1
[LiteratureReference:5665948] Crystal structures of a Formin Homology-2 domain reveal a tethered dimer architecture
[LiteratureReference:5672362] Structure of the autoinhibitory switch in formin mDia1
[LiteratureReference:8874559] Structural basis for the autoinhibition of focal adhesion kinase
[LiteratureReference:9665365] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
[LiteratureReference:9691847] Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
[LiteratureReference:9710814] The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Eck, Michael J (2408401)